scholarly journals Plasma biomarkers of neurodegeneration and neuroinflammation in hospitalized COVID‐19 patients with and without new neurological symptoms

2021 ◽  
Vol 17 (S5) ◽  
Author(s):  
Allal Boutajangout ◽  
Jennifer Frontera ◽  
Ludovic Debure ◽  
Alok Vedvyas ◽  
Arline Faustin ◽  
...  
Anaesthesia ◽  
2000 ◽  
Vol 55 (10) ◽  
pp. 1020-1024 ◽  
Author(s):  
K. De Weert ◽  
M. Traksel ◽  
M. Gielen ◽  
R. Slappendel ◽  
E. Weber ◽  
...  

2013 ◽  
Author(s):  
Ying-Ray Lee ◽  
Chieh-Hsiang Lu ◽  
Hong-Lin Chan

2020 ◽  
Vol 78 (8) ◽  
pp. 494-500 ◽  
Author(s):  
Adalberto STUDART-NETO ◽  
Bruno Fukelmann GUEDES ◽  
Raphael de Luca e TUMA ◽  
Antonio Edvan CAMELO FILHO ◽  
Gabriel Taricani KUBOTA ◽  
...  

ABSTRACT Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing neurological conditions may require special treatment and may be associated with worse outcomes. Notwithstanding, the role of neurologists in COVID-19 is probably underrecognized. Objective: The aim of this study was to report the reasons for requesting neurological consultations by internists and intensivists in a COVID-19-dedicated hospital. Methods: This retrospective study was carried out at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil, a 900-bed COVID-19 dedicated center (including 300 intensive care unit beds). COVID-19 diagnosis was confirmed by SARS-CoV-2-RT-PCR in nasal swabs. All inpatient neurology consultations between March 23rd and May 23rd, 2020 were analyzed. Neurologists performed the neurological exam, assessed all available data to diagnose the neurological condition, and requested additional tests deemed necessary. Difficult diagnoses were established in consensus meetings. After diagnosis, neurologists were involved in the treatment. Results: Neurological consultations were requested for 89 out of 1,208 (7.4%) inpatient COVID admissions during that period. Main neurological diagnoses included: encephalopathy (44.4%), stroke (16.7%), previous neurological diseases (9.0%), seizures (9.0%), neuromuscular disorders (5.6%), other acute brain lesions (3.4%), and other mild nonspecific symptoms (11.2%). Conclusions: Most neurological consultations in a COVID-19-dedicated hospital were requested for severe conditions that could have an impact on the outcome. First-line doctors should be able to recognize neurological symptoms; neurologists are important members of the medical team in COVID-19 hospital care.


Author(s):  
Andrea Sciarrone ◽  
Igor Bisio ◽  
Chiara Garibotto ◽  
Fabio Lavagetto ◽  
Mehrnaz Hamedani ◽  
...  

Author(s):  
Maoqing Wang ◽  
Zhiping Long ◽  
Jingshen Tian ◽  
Songjie Chen ◽  
Hongru Sun ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document